Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Tesar

Showing results (161-170 of 193) with videos related to

Pageof 20
Sort By:
The New England Journal of Medicine|April 1, 2009
Rosuvastatin and cardiovascular events in patients undergoing hemodialysisBengt C Fellström, Alan G Jardine, Roland E Schmieder, et al.
Annals of the Rheumatic Diseases|March 30, 2020
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritisAntonis Fanouriakis, Myrto Kostopoulou, Kim Cheema, et al.
Kidney International|September 5, 2020
HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipientsLena Berchtold, Eric Letouzé, Mariam Priya Alexander, et al.
The New England Journal of Medicine|November 3, 2023
Sparsentan versus Irbesartan in Focal Segmental GlomerulosclerosisMichelle N Rheault, Charles E Alpers, Jonathan Barratt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2018
Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney OutcomesMeggan Mackay, Maria Dall'Era, Joanna Fishbein, et al.
Kidney International Supplements|March 10, 2020
Considerations on equity in management of end-stage kidney disease in low- and middle-income countriesWim Van Biesen, Vivekanand Jha, Ali K Abu-Alfa, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 30, 2020
Developments in the Histopathological Classification of ANCA-Associated GlomerulonephritisEmma E van Daalen, Maria A C Wester Trejo, Arda Göçeroğlu, et al.
Annals of the Rheumatic Diseases|July 10, 2026
Development and validation of EULAR quality indicators for lupus nephritis: adherence trends and impact on clinical outcomesΕda Otman Akat, Myrto Kostopoulou, Spyridon Katechis, et al.
Kidney International|April 4, 2014
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatmentsRosanna Coppo, Stéphan Troyanov, Shubha Bellur, et al.
Annals of the Rheumatic Diseases|August 2, 2012
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritisGeorge K Bertsias, Maria Tektonidou, Zahir Amoura, et al.
Pageof 20

Showing results (161-170 of 193) with videos related to

Sort By:
Pageof 20
The New England Journal of Medicine|April 1, 2009
Rosuvastatin and cardiovascular events in patients undergoing hemodialysisBengt C Fellström, Alan G Jardine, Roland E Schmieder, et al.
Annals of the Rheumatic Diseases|March 30, 2020
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritisAntonis Fanouriakis, Myrto Kostopoulou, Kim Cheema, et al.
Kidney International|September 5, 2020
HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipientsLena Berchtold, Eric Letouzé, Mariam Priya Alexander, et al.
The New England Journal of Medicine|November 3, 2023
Sparsentan versus Irbesartan in Focal Segmental GlomerulosclerosisMichelle N Rheault, Charles E Alpers, Jonathan Barratt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2018
Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney OutcomesMeggan Mackay, Maria Dall'Era, Joanna Fishbein, et al.
Kidney International Supplements|March 10, 2020
Considerations on equity in management of end-stage kidney disease in low- and middle-income countriesWim Van Biesen, Vivekanand Jha, Ali K Abu-Alfa, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 30, 2020
Developments in the Histopathological Classification of ANCA-Associated GlomerulonephritisEmma E van Daalen, Maria A C Wester Trejo, Arda Göçeroğlu, et al.
Annals of the Rheumatic Diseases|July 10, 2026
Development and validation of EULAR quality indicators for lupus nephritis: adherence trends and impact on clinical outcomesΕda Otman Akat, Myrto Kostopoulou, Spyridon Katechis, et al.
Kidney International|April 4, 2014
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatmentsRosanna Coppo, Stéphan Troyanov, Shubha Bellur, et al.
Annals of the Rheumatic Diseases|August 2, 2012
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritisGeorge K Bertsias, Maria Tektonidou, Zahir Amoura, et al.
Pageof 20